Cargando…
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
Telmisartan is an angiotensin II receptor antagonist, which selectively inhibits the angiotensin II type 1 receptor. Thus, it is widely used for hypertension management. Nowadays, telmisartan’s effect on peroxisome proliferator-activated receptors (PPARs) is gaining wider attention. PPARs are ligand...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567533/ https://www.ncbi.nlm.nih.gov/pubmed/33116714 http://dx.doi.org/10.2147/DMSO.S265399 |